| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |